Skip to main content

Schmerztherapie beim Prostatakarzinom

  • Conference paper
  • 19 Accesses

Zusammenfassung

Nach einer Zusammenstellung von Twycross leiden 60–75% aller Patienten mit malignen urologischen Erkrankungen unter Schmerzen, die oft ganz im Vordergrund der Symptomatik stehen (Twycross u. Lack 1983). Dennoch werden — im Vergleich zur kausalen Therapie — analgetische Maßnahmen häufig vernachlässigt, so daß viele Kranke bis zu ihrem Tod stärksten Schmerz ertragen müssen (Hymes 1986). Das Ziel einer adäquaten Behandlung von Tumorpatienten darf nach heutigem Verständnis nicht nur die Verlängerung der Lebensdauer sein. Zur Erhaltung einer akzeptablen Lebensqualität ist eine gleichzeitige analgetische Versorgung unverzichtbar.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Allen KL, Johnson TW, Hibbs G (1976) Effective bone palliation as related to various treatment regimens. Cancer 37:984–987

    Article  PubMed  CAS  Google Scholar 

  • American Pain Society (1987) Principles of analgesic use in the treatment of acute pain or chronic cancer pain. Clin Pharm 6:523–532

    Google Scholar 

  • Benson RC, Hasan SM, Jones AG, Schlise S (1982) External beam radiotherapy for palliation of pain from metastatic carcinoma of the prostate. J Urol 127:69–71

    PubMed  Google Scholar 

  • Bonica JJ (1990) Cancer pain. In: Bonica JJ (ed) The management of pain, 2nd edn. Lea & Febiger, Philadelphia, pp 400–460

    Google Scholar 

  • Daut RL, Cleeland CS (1982) The prevalence and severity of pain in cancer. Cancer 50:1913–1918

    Article  PubMed  CAS  Google Scholar 

  • Flamm J, Burkert S (1981) Radioaktive Substanzen (32P und 89Sr) in der Schmerzbehandlung bei Knochenmetastasen. Z Urol Nephrol 74:801–806

    PubMed  CAS  Google Scholar 

  • Foley KM (1985) The treatment of cancer pain. N Engl J Med 313:84–95

    Article  PubMed  CAS  Google Scholar 

  • Gilbert HA, Kagan AR, Nussbaum H et al. (1977) Evaluation of radiation therapy for bone metastases: pain relief and quality of life. AJR 129:1095–1096

    PubMed  CAS  Google Scholar 

  • Glaser MG, Howard N, Waterfall N (1981) Carcinoma of the prostate: the treatment of bone metastases by radiophosphorus. Clin Radiology 32:695–697

    Article  CAS  Google Scholar 

  • Grond S, Zech D, Schug SA, Meuser T, Stobbe B, Lehmann KA (1989) Schmerzdiagnose und Schmerztherapie bei malignen urologischen Erkrankungen. Aktuel Urol 20:300–306

    Article  Google Scholar 

  • Hymes J (1986) Cancer pain management. In: Graham SD (ed) Urologic oncology. Raven, New York, pp 447–457

    Google Scholar 

  • International Association for the Study of Pain (1986) Classification of chronic pain. Pain [Suppl 3]:1–226

    Google Scholar 

  • Jensen MP (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126

    Article  PubMed  CAS  Google Scholar 

  • Lehmann KA (1990) Opioide and Antagonisten. Klinische Pharmakologie für Anästhesisten, Intensivmediziner und Schmerztherapeuten. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Lehmann KA, Zech D (eds) (1991) Transdermal fentanyl. A new approach to prolonged pain control. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Lewington VJ, McEwan AJ, Ackery DM (1991) A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 27:954–958

    Article  PubMed  CAS  Google Scholar 

  • Lloyd JW, Rawlinson WAL, Evans PJD (1981) Selective hypophysectomy for metastatic pain. A review of ethyl alcohol ablation of the anterior pituitary in a regional pain relief unit. Br J Anaesth 53:1129–1133

    Article  PubMed  CAS  Google Scholar 

  • Maxon HR, Schroder LE, Thomas SR et al. (1990) Re-186 (Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology 176:155–159

    PubMed  Google Scholar 

  • McQuay HJ (1989) Opioids in chronic pain. Br J Anaesth 63:213–216

    Article  PubMed  CAS  Google Scholar 

  • Pannuti F, Martoni A, Rossi AP, Piana E (1979) The role of endocrine therapy for relief of pain due to advanced cancer. Adv Pain Res Ther 2:145–165

    Google Scholar 

  • Paulson DF (1989) The management of pain with end-stage prostatic malignancy. Probl Urol 3:307–323

    Google Scholar 

  • Payne R (1987) Role of epidural and intrathecal narcotics and peptides in the management of cancer pain. Med Clin North Am 71:313–327

    PubMed  CAS  Google Scholar 

  • Penn CRH (1976) Single dose and fractionated palliative irradiation for osseous metastases. Clin Radiology 27:405–408

    Article  CAS  Google Scholar 

  • Pollen JJ, Schmidt JD (1979) Bone pain in metastatic cancer of prostate. Urology 13:129–134

    Article  PubMed  CAS  Google Scholar 

  • Portenoy RK, Hagen NA (1991) Breakthrough pain: definition, prevalence and characteristics. Pain 41:273–281

    Article  Google Scholar 

  • Schoon W, Erdmann H, Kleeberg UR (1987) Die kontinuierliche subkutane Opioidinfusion in der onkologischen Schmerztherapie. Med Klin 82:805–811

    CAS  Google Scholar 

  • Stoll BA (1981) Breast and prostatic cancer: methods and results of endocrine therapy. In: Stoll BA (ed) Hormonal management of endocrine-related cancer. Lloyd-Luke, London, pp 77–91, 148–157

    Google Scholar 

  • Sundaresan N, DiGiacinto GV (1987) Antitumor and antinociceptive approaches to control cancer pain. Med Clin North Am 71:329–348

    PubMed  CAS  Google Scholar 

  • Twycross RG, Lack SA (1983) Symptom control in far advanced cancer: pain relief. Pitman, London

    Google Scholar 

  • Varga ZA, Clicksman AS, Boland J (1969) Single-dose radiation therapy in the palliation of metastatic disease. Radiology 93:1181–1184

    Google Scholar 

  • Ventafridda V, Saita L, Ripamonti C, De Conno F (1985) WHO Guidelines for the use of analgesics in cancer pain. Int J Tissue React 7:93–96

    PubMed  CAS  Google Scholar 

  • Woo R, Seltzer JL (1987) Pain control for the urologist. Urol Clin North Am 14:405–417

    PubMed  CAS  Google Scholar 

  • World Health Organisation (1986) Cancer pain relief. Geneva

    Google Scholar 

  • World Health Organisation (1990) Cancer pain relief and palliative care. Report of a WHO expert committee. Geneva

    Google Scholar 

  • Zech D, Schug SA, Horsch M (1988) Therapiekompendium Tumorschmerz. Perimed, Erlangen

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lehmann, K.A., Grond, S., Zech, D. (1993). Schmerztherapie beim Prostatakarzinom. In: Nagel, R. (eds) Zur Therapie des Prostatakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78164-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78164-3_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56597-0

  • Online ISBN: 978-3-642-78164-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics